Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joincare Pharmaceutical Group Industry Co Days Payable Chart
Joincare Pharmaceutical Group Industry Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joincare Pharmaceutical Group Industry Co Days Payable vs Drug Manufacturers Industry
Joincare Pharmaceutical Group Industry Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joincare Pharmaceutical Group Industry Co (FRA:F9L) has a Days Payable of 126.61 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. This is near median its historical median of 127.72. Over the past decade, Joincare Pharmaceutical Group Industry Co's Days Payable has ranged from 102.62 to 146.93. According to the industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #284 out of 925 companies in the Drug Manufacturers industry, placing it in the top 30.7%.
Is Joincare Pharmaceutical Group Industry Co's Days Payable too high?
Joincare Pharmaceutical Group Industry Co's current Days Payable of 126.61 is near median its 10-year median of 127.72. Over the past 10 years, this metric has ranged from a low of 102.62 to a high of 146.93. The Drug Manufacturers industry median Days Payable is 89.27. Joincare Pharmaceutical Group Industry Co's value of 126.61 is 41.8% above this industry median. Based on the distribution chart, Joincare Pharmaceutical Group Industry Co ranks #284 out of 925 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #284 out of 925 companies for Days Payable. This puts Joincare Pharmaceutical Group Industry Co in the upper half of its industry. The industry median Days Payable is 89.27. Joincare Pharmaceutical Group Industry Co's value of 126.61 is 41.8% above this benchmark. Historically, Joincare Pharmaceutical Group Industry Co's own Days Payable has ranged from 102.62 to 146.93 over the past decade. While the company's 10-year median is 127.72 vs. the industry median of 89.27, Joincare Pharmaceutical Group Industry Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 89.27, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joincare Pharmaceutical Group Industry Co's current Days Payable of 126.61 is 41.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 89.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joincare Pharmaceutical Group Industry Co's current Days Payable is 126.61, which is near median its own 10-year median of 127.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Joincare Pharmaceutical Group Industry Co (FRA:F9L) has a current Days Payable of 126.61. The stock's GF Value™ is €7.53, compared to a current price of €6.60 — trading 12.4% below its estimated fair value. The current Days Payable is 126.61, which is near median its 10-year median of 127.72 and 41.8% above the Drug Manufacturers industry median of 89.27. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (FRA:F9L), the current Days Payable is 126.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joincare Pharmaceutical Group Industry Co (FRA:F9L) Overvalued in 2026?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued.
The current stock price of €6.60 is trading 12.4% below its estimated GF Value™ of €7.53.
Key valuation signals for FRA:F9L:
Days Payable: 126.61 (near median its 10-year median of 127.72)
GF Value™: €7.53 vs. price of €6.60 (12.4% below fair value)
Industry Position: 41.8% above the Drug Manufacturers median (#284 of 925)
No single metric tells the full story. See the FRA:F9L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score
Get the complete analysis for FRA:F9L
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:F9L has been successfully added to your 
